分化型甲状腺癌的淋巴闪烁显像。

Lymphoscintigraphy in Differentiated Thyroid Cancer.

机构信息

From the *Department of Surgery, University of Padova, Padova, Italy †Médecine Nucléaire-Groupement Hospitalier Est, Bron, France; ‡Department of Nuclear Medicine, Santa Maria della Misericordia Hospital, Rovigo, Italy; and §Department of Radiology, University of Southern California, LAC+USC Medical Center, Los Angeles, CA.

出版信息

Clin Nucl Med. 2015 Jul;40(7):e343-50. doi: 10.1097/RLU.0000000000000825.

DOI:10.1097/RLU.0000000000000825

PMID:26018703

Abstract

There is considerable variability in the surgical approach to differentiated thyroid cancer regarding the decision to explore and remove central or central and lateral compartment lymph nodes. Much as sentinel lymph node sampling has improved the decision to remove axillary nodes for breast cancer, vital dye and lymphoscintigraphy with lymph node sampling may direct the surgical approach to differentiated thyroid cancer.

摘要

在分化型甲状腺癌的手术治疗中，对于是否探查和切除中央或中央和侧方颈部淋巴结，存在相当大的差异。就像前哨淋巴结活检术改善了乳腺癌腋窝淋巴结切除的决策一样，放射性核素示踪染料和淋巴结活检术的淋巴闪烁显像术可能指导分化型甲状腺癌的手术治疗方法。